Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?

By T. Takada, Hodaka Amano, H. Yasuda, Y. Nimura, T. Matsushiro, H. Kato, T. Nagakawa, T. Nakayama. Cancer, 2002

624 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/4f66b6926ef9c1d67c93db0ed141dd6cdeeb2b74

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Jennifer J. Knox
2. T. Walter
3. A. Horgan
4. E. Amir

Citations in the corpus

• Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. (2012, methodology): “Margin and Node Positivity Nine studies reporting nodal (n 464) or margin positivity (n 340) as per our prespecified definition ( 50%) were analyzed independently.(13,17,18,22,24,25,29-31) Pooled data confirmed a significant benefit for any adjuvant therapy (n 230) in node-positive disease (OR, 0.”
• Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages (2010, background): “Here, solid data from randomized controlled trials [17–22] suggest that adjuvant chemotherapy (gemcitabine or 5-FU) is the standard treatment option.”